WALTHAM, Mass.–(BUSINESS WIRE)–Vizgen, Inc., a leader in spatial multi-omics, today announced the closing of a $48 million financing. The financing was led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures with…
Funding will support a planned Phase III U.S. clinical trial in 2026 CAMBRIDGE, Mass.–(BUSINESS WIRE)–MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative diseases, today announced that its…
Financing round led by RA Capital Management and Forge Life Science Partners, with contributions from new and existing investors Proceeds to advance frevecitinib, an inhaled pan-JAK inhibitor with the potential to treat the broad severe…
BOSTON, Dec. 17, 2025 /PRNewswire/ — CranioSense, Inc., a neurotechnology company developing the world’s first noninvasive intracranial pressure (ICP) diagnostic and monitoring system, today announced the award of approximately $5.5 million in total non-dilutive funding through the NIH Blueprint…
BOSTON–(BUSINESS WIRE)–PairSoft, a leading provider of procure-to-pay automation and payment solutions, today announced a majority investment from TA Associates (“TA”), a leading global private equity firm. The partnership will support PairSoft’s continued product enhancement, innovation…
The new funding cements Manifold’s leadership in the $2 trillion life sciences market, powering next-generation AI workflows from early discovery through precision care. NEWTON, Mass.–(BUSINESS WIRE)–Manifold, the AI platform for life sciences, today announced an…
Funding fuels expansion of Neurable AI as cognitive health becomes the next major category in consumer tech BOSTON–(BUSINESS WIRE)–Neurable, the leader in noninvasive brain-computer interface (BCI) technology designed for everyday life, today announced it has…
Series C Round Led by Menlo Ventures with Participation from NVentures, Hallwood Media, Lightspeed, and Matrix CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ — Suno, a music company built to amplify imagination powered by the world’s most advanced AI…
Company Raised $112 Million to Date and is on Track to Generate Initial Clinical Data by Year End BURLINGTON, Mass.–(BUSINESS WIRE)–Lifordi Immunotherapeutics, Inc., a clinical-stage biotech company developing antibody-drug conjugates (ADCs) for the treatment of…
BOSTON–(BUSINESS WIRE)–AI Proteins, a biotech company pioneering a new class of de novo medicines built from the ground up using artificial intelligence, today announced the closing of a $41.5 million Series A financing. The round was led…